Managers / Q2 2025 · view latest →
Samson Rock Capital LLP
CIK 0001788558 · 58 GREAT MARLBOROUGH STREET, LONDON, X0, W1F 7JY · 00442039941800
Summary
Samson Rock Capital LLP reported $25M in U.S.-listed holdings across 6 positions for Q2 2025.
The portfolio is heavily concentrated: HES alone accounts for 56.0% of reported value.
Compared with Q1 2025, the fund opened 4 new positions and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 60.4% · $15M
- REIT · 39.1% · $10M
- ADR · 0.6% · $138,210
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| EFCMAC Copper Limited | NEW | +800.0K | 800.0K | +$10M | $10M |
| KELKellanova | NEW | +10.0K | 10.0K | +$795,300 | $795,300 |
| BGCBgc Group Inc | NEW | +17.4K | 17.4K | +$178,002 | $178,002 |
| VEONVEON Ltd | NEW | +3.0K | 3.0K | +$138,210 | $138,210 |
| SOLVSolventum Corp | TRIMMED | −31.5K | 1.5K | −$2M | $113,760 |
| HESHess Corp | TRIMMED | −220.0K | 100.0K | −$37M | $14M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | HESHess Corphistory → | COM | 55.97% | $14M | 100.0K |
| 2 | EFCMAC Copper Limitedhistory → | ORD SHS | 39.08% | $10M | 800.0K |
| 3 | KELKellanovahistory → | COM | 3.21% | $795,300 | 10.0K |
| 4 | BGCBgc Group Inc | CL A | 0.72% | $178,002 | 17.4K |
| 5 | VEONVEON Ltd | SPONSORED ADS | 0.56% | $138,210 | 3.0K |
| 6 | SOLVSolventum Corp | COM SHS | 0.46% | $113,760 | 1.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2026 | $46M | 4 | Jul 1, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q1 2026 | $67M | 2 | Apr 28, 2026 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2025 | $61M | 3 | Jan 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $38M | 3 | Oct 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $25M | 6 | Aug 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $54M | 2 | Apr 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $130M | 8 | Jan 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $98M | 8 | Oct 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $135M | 5 | Jul 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $128M | 10 | May 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $95M | 10 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $309M | 42 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $66M | 18 | Aug 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $195M | 12 | Apr 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $117M | 19 | Feb 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $133M | 40 | Nov 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $82M | 21 | Jul 22, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | Under review | 23 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | Under review | 16 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $158M | 69 | Oct 18, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $508M | 25 | Jul 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $400M | 52 | May 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $170M | 15 | Feb 3, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.